142 related articles for article (PubMed ID: 35536636)
1. Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination.
Kreuter A; Lausch S; Burmann SN; Paschos A; Michalowitz AL
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e669-e672. PubMed ID: 35536636
[No Abstract] [Full Text] [Related]
2. Dermatomyositis following COVID-19 vaccination.
Venkateswaran K; Aw DC; Huang J; Angkodjojo S
Dermatol Ther; 2022 Jun; 35(6):e15479. PubMed ID: 35355380
[No Abstract] [Full Text] [Related]
3. Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Lung Disease After Vaccination With COVID-19 mRNA Vaccines.
Kitajima T; Funauchi A; Nakajima T; Marumo S; Imura Y; Fukui M
J Rheumatol; 2022 Oct; 49(10):1158-1162. PubMed ID: 35705246
[TBL] [Abstract][Full Text] [Related]
4. New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review.
Holzer MT; Krusche M; Ruffer N; Haberstock H; Stephan M; Huber TB; Kötter I
Rheumatol Int; 2022 Dec; 42(12):2267-2276. PubMed ID: 35939078
[TBL] [Abstract][Full Text] [Related]
5. Immediate reactions after mRNA SARS-CoV-2 vaccination.
Jeimy S; Wong T; Song C
CMAJ; 2021 Dec; 193(48):E1842. PubMed ID: 34772737
[No Abstract] [Full Text] [Related]
6. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
Hinterseher J; Hertl M; Didona D
J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
[TBL] [Abstract][Full Text] [Related]
7. Disease flare in patients with dermatomyositis following COVID-19 vaccination.
Pan CX; Goldman N; Kim DY; Rowley R; Schaefer M; LaChance AH; Nambudiri VE
J Am Acad Dermatol; 2022 Dec; 87(6):1373-1374. PubMed ID: 35817330
[No Abstract] [Full Text] [Related]
8. [Facing COVID-19 : myocarditis following vaccination with mRNA SARS-CoV-2].
Weerts V; Lempereur M; Léonard P; Lancellotti P
Rev Med Liege; 2023 Mar; 78(3):141-146. PubMed ID: 36924151
[TBL] [Abstract][Full Text] [Related]
9. Dermatomyositis in Association With SARS-CoV-2 Infection or COVID-19 Vaccine.
Diaz-Menindez M; Sullivan MM; Wang B; Majithia V; Abril A; Butendieck RR; Ball CT; Berianu F
Arthritis Care Res (Hoboken); 2024 Jan; 76(1):98-104. PubMed ID: 37728071
[TBL] [Abstract][Full Text] [Related]
10. Comment on: Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination.
Panigrahi PK
Indian J Ophthalmol; 2022 May; 70(5):1862. PubMed ID: 35502108
[No Abstract] [Full Text] [Related]
11. Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination.
Hansbauer M; Fastantz E; Lutz J; Hasan A
J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):502-503. PubMed ID: 35916561
[No Abstract] [Full Text] [Related]
12. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
13. Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity.
Edgerley S; Jeimy S; Zhu R
CMAJ; 2022 Jun; 194(23):E807-E811. PubMed ID: 35697371
[No Abstract] [Full Text] [Related]
14. Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore.
Tu TM; Yi SJ; Koh JS; Saffari SE; Hoe RHM; Chen GJ; Chiew HJ; Tham CH; Seet CYH; Yong MH; Yong KP; Hui AC; Fan BE; Tan BY; Quek AML; Seet RCS; Yeo LLL; Tan K; Thirugnanam UN
JAMA Netw Open; 2022 Mar; 5(3):e222940. PubMed ID: 35297971
[TBL] [Abstract][Full Text] [Related]
15. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
16. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
Maeda M; Isawa T; Tada N
Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
[No Abstract] [Full Text] [Related]
17. New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review.
Mohamed A; Tzoulis P; Kossler AL; Dosiou C
J Clin Endocrinol Metab; 2023 Mar; 108(4):979-985. PubMed ID: 36251747
[TBL] [Abstract][Full Text] [Related]
18. [A case of severe inflammatory bowel disease triggered by vaccination with SARS-CoV-2 mRNA].
Takahashi Y; Shimodaira Y; Yoshida T; Tajika M; Takahashi S; Watanabe K; Fukuda S; Koizumi S; Matsuhashi T; Iijima K
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(4):325-329. PubMed ID: 37032096
[TBL] [Abstract][Full Text] [Related]
19. Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.
Yoshida T; Tsuji H; Onishi A; Takase Y; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Tanaka M; Yoshifuji H; Morinobu A
Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35961691
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis of central retinal artery occlusion after mRNA-SARS-CoV-2 vaccination.
Au SCL
QJM; 2022 Dec; 115(12):880-881. PubMed ID: 35088861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
